Cormorant Asset Management, LP Alx Oncology Holdings Inc Put Options Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALXO
# of Institutions
115Shares Held
38.4MCall Options Held
132KPut Options Held
19.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$58.5 Million42.27% of portfolio
-
Redmile Group, LLC San Francisco, CA4.33MShares$26.1 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$25.4 Million6.29% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.72MShares$16.4 Million0.68% of portfolio
-
Vestal Point Capital, LP New York, NY2.61MShares$15.7 Million2.41% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $246M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...